TargTex Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- (In Progress)
- Investors
-
7
TargTex General Information
Description
Operator of a biotech company intended to treat glioblastoma multiforme. The company's therapeutics specializes in artificial intelligence algorithms that decipher a relationship between an unexplored target, like a calcium channel, and a small molecule with known anti-cancer properties, enabling scientists, physicians, and patients to have clinical candidates for different oncological indications.
Contact Information
Website
www.targtex.comCorporate Office
- Avenida Tenente Valadim
- Number 17, 2nd Floor
- Torres Vedras, 2560-275
- Portugal
Corporate Office
- Avenida Tenente Valadim
- Number 17, 2nd Floor
- Torres Vedras, 2560-275
- Portugal
TargTex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 14-Oct-2026 | In Progress | Generating Revenue | |||
| 5. Grant | 21-Jun-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 14-Feb-2022 | Completed | Generating Revenue | |||
| 3. Grant | 27-Nov-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 26-Jun-2019 | $1.41M | $1.41M | Completed | Startup | |
| 1. University Spin-Out | 01-Jun-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
TargTex Patents
TargTex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024400179-A1 | Chemotherapeutic agent and compositions | Pending | 12-Dec-2023 | ||
| EP-4823540-A1 | Chemotherapeutic agent and compositions | Pending | 12-Dec-2023 | ||
| WO-2025125509-A1 | Chemotherapeutic agent and compositions | Inactive | 12-Dec-2023 | A61K9/0085 |
TargTex Signals
TargTex Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Laboratorios Basi | Corporation | Minority | ||
| Horizon 2020 | Government | |||
| Ignition Capital | Venture Capital | Minority | ||
| Portugal Ventures | Venture Capital | Minority |
TargTex FAQs
-
When was TargTex founded?
TargTex was founded in 2019.
-
Where is TargTex headquartered?
TargTex is headquartered in Torres Vedras, Portugal.
-
What is the size of TargTex?
TargTex has 9 total employees.
-
What industry is TargTex in?
TargTex’s primary industry is Drug Discovery.
-
Is TargTex a private or public company?
TargTex is a Private company.
-
What is TargTex’s current revenue?
The current revenue for TargTex is .
-
How much funding has TargTex raised over time?
TargTex has raised $3.67M.
-
Who are TargTex’s investors?
European Innovation Council, Laboratorios Basi, Horizon 2020, Ignition Capital, and Portugal Ventures are 5 of 7 investors who have invested in TargTex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process